Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 28

1.

Mine drainage: Treatment technologies and rare earth elements.

Wei X, Zhang S, Shimko J, Dengler RW 2nd.

Water Environ Res. 2019 Jul 10. doi: 10.1002/wer.1178. [Epub ahead of print] Review.

PMID:
31291681
2.

Histone core phosphorylation regulates DNA accessibility.

Brehove M, Wang T, North J, Luo Y, Dreher SJ, Shimko JC, Ottesen JJ, Luger K, Poirier MG.

J Biol Chem. 2015 Sep 11;290(37):22612-21. doi: 10.1074/jbc.M115.661363. Epub 2015 Jul 13.

3.

Chemical and biological tools for the preparation of modified histone proteins.

Howard CJ, Yu RR, Gardner ML, Shimko JC, Ottesen JJ.

Top Curr Chem. 2015;363:193-226. doi: 10.1007/128_2015_629.

4.

Preparing semisynthetic and fully synthetic histones h3 and h4 to modify the nucleosome core.

Shimko JC, Howard CJ, Poirier MG, Ottesen JJ.

Methods Mol Biol. 2013;981:177-92. doi: 10.1007/978-1-62703-305-3_14.

5.

Regulation of the nucleosome unwrapping rate controls DNA accessibility.

North JA, Shimko JC, Javaid S, Mooney AM, Shoffner MA, Rose SD, Bundschuh R, Fishel R, Ottesen JJ, Poirier MG.

Nucleic Acids Res. 2012 Nov 1;40(20):10215-27. doi: 10.1093/nar/gks747. Epub 2012 Sep 10.

6.

A reversible protection strategy to improve Fmoc-SPPS of peptide thioesters by the N-Acylurea approach.

Mahto SK, Howard CJ, Shimko JC, Ottesen JJ.

Chembiochem. 2011 Nov 4;12(16):2488-94. doi: 10.1002/cbic.201100472. Epub 2011 Sep 12. Erratum in: Chembiochem. 2011 Nov 4;12(16):2386.

7.

Histone fold modifications control nucleosome unwrapping and disassembly.

Simon M, North JA, Shimko JC, Forties RA, Ferdinand MB, Manohar M, Zhang M, Fishel R, Ottesen JJ, Poirier MG.

Proc Natl Acad Sci U S A. 2011 Aug 2;108(31):12711-6. doi: 10.1073/pnas.1106264108. Epub 2011 Jul 18.

8.

Preparation of fully synthetic histone H3 reveals that acetyl-lysine 56 facilitates protein binding within nucleosomes.

Shimko JC, North JA, Bruns AN, Poirier MG, Ottesen JJ.

J Mol Biol. 2011 Apr 29;408(2):187-204. doi: 10.1016/j.jmb.2011.01.003. Epub 2011 Feb 15.

9.

Abstracts of the ophthalmic literature.

Cline C, Fray K, Gallagher C, Huebner A, Pendarvis L, Pritchard C, Rocha-Gamba I, Shimko J, Arnoldi K.

Am Orthopt J. 2009;59:120-69. doi: 10.3368/aoj.59.1.120. No abstract available.

PMID:
21149198
10.

Abstracts of the ophthalmic literature.

Fray K, Huebner A, Cline C, Shimko J, Rocha-Gamba I, Pritchard C, Gallagher C, Arnoldi K.

Am Orthopt J. 2008;58:116-56. doi: 10.3368/aoj.58.1.116. No abstract available.

PMID:
21149186
11.

Randomised, double-blind, safety and efficacy of a killed oral vaccine for enterotoxigenic E. Coli diarrhoea of travellers to Guatemala and Mexico.

Sack DA, Shimko J, Torres O, Bourgeois AL, Francia DS, Gustafsson B, Kärnell A, Nyquist I, Svennerholm AM.

Vaccine. 2007 May 30;25(22):4392-400. Epub 2007 Apr 4.

PMID:
17448578
12.

Abstracts of the ophthalmic literature.

Fray K, Pritchard C, Shimko J, Brock AH, Cline CT, Gallagher C, Rocha-Gamba I, Arnoldi K.

Am Orthopt J. 2007;57:148-90. doi: 10.3368/aoj.57.1.148. No abstract available.

PMID:
21149173
13.

Comparative safety and immunogenicity of two attenuated enterotoxigenic Escherichia coli vaccine strains in healthy adults.

McKenzie R, Bourgeois AL, Engstrom F, Hall E, Chang HS, Gomes JG, Kyle JL, Cassels F, Turner AK, Randall R, Darsley M, Lee C, Bedford P, Shimko J, Sack DA.

Infect Immun. 2006 Feb;74(2):994-1000.

14.

Abstracts of the ophthalmic literature.

Shimko J, Huebner A, Fray K, Rocha-Gamba I, Pritchard C, Beneish R, Cline C, Duncan C, McFarlane W, Arnoldi K.

Am Orthopt J. 2006;56:204-48. doi: 10.3368/aoj.56.1.204. No abstract available.

PMID:
21149154
16.

Evaluation of Salmonella enterica serovar Typhi (Ty2 aroC-ssaV-) M01ZH09, with a defined mutation in the Salmonella pathogenicity island 2, as a live, oral typhoid vaccine in human volunteers.

Kirkpatrick BD, McKenzie R, O'Neill JP, Larsson CJ, Bourgeois AL, Shimko J, Bentley M, Makin J, Chatfield S, Hindle Z, Fidler C, Robinson BE, Ventrone CH, Bansal N, Carpenter CM, Kutzko D, Hamlet S, LaPointe C, Taylor DN.

Vaccine. 2006 Jan 12;24(2):116-23. Epub 2005 Aug 18.

PMID:
16140433
17.

Abstracts of the ophthalmic literature.

Shimko J, Pritchard C, Gallagher C, Fray K, Arnoldi K, McFarlane W, Rocha-Gamba I, Beneish R, Huebner A, van Almsick C.

Am Orthopt J. 2004;54:167-208. doi: 10.3368/aoj.54.1.167. No abstract available.

PMID:
21149107
18.

Case Corner: Treatment of amblyopia in the setting of unilateral high myopia.

Shimko JW.

Am Orthopt J. 2004;54:158-63. doi: 10.3368/aoj.54.1.158. No abstract available.

PMID:
21149103
19.

Abstracts of the ophthalmic literature.

Shimko J, Pritchard C, Gallagher C, Fray K, Arnoldi K, McFarlane W, Rocha-Gamba I.

Am Orthopt J. 2003;53:143-79. doi: 10.3368/aoj.53.1.143. No abstract available.

PMID:
21149086
20.

Case Corner: Obstacles to fusion in strabismus patients.

Shimko JW.

Am Orthopt J. 2003;53:138-42. doi: 10.3368/aoj.53.1.138. No abstract available.

PMID:
21149085
21.
22.

Abstracts of the ophthalmic literature.

Shimko J, Pritchard C, Springer C, Gallagher C, Fray K, Arnoldi K, McFarlane W, Rocha-Gamba I, Beneish R.

Am Orthopt J. 2002;52:126-60. doi: 10.3368/aoj.52.1.126. No abstract available.

PMID:
21149071
23.

Case Corner: Management of patients with thyroid ophthalmopathy.

Shimko JW.

Am Orthopt J. 2002;52:114-20. doi: 10.3368/aoj.52.1.114. No abstract available.

PMID:
21149066
24.

Abstracts of the ophthalmic literature.

Shimko JF, Pritchard C, Springer C, Gallagher C, Fray K, Arnoldi K, McFarlane W, Rocha-Gamba I.

Am Orthopt J. 2001;51:164-200. doi: 10.3368/aoj.51.1.164. No abstract available.

PMID:
21149053
25.

Case Corner: Evaluation and treatment of dissociated vertical deviation.

Shimko JF.

Am Orthopt J. 2001;51:154-9. doi: 10.3368/aoj.51.1.154. No abstract available.

PMID:
21149048
26.

Validation of a volunteer model of cholera with frozen bacteria as the challenge.

Sack DA, Tacket CO, Cohen MB, Sack RB, Losonsky GA, Shimko J, Nataro JP, Edelman R, Levine MM, Giannella RA, Schiff G, Lang D.

Infect Immun. 1998 May;66(5):1968-72.

27.

Evaluation of Peru-15, a new live oral vaccine for cholera, in volunteers.

Sack DA, Sack RB, Shimko J, Gomes G, O'Sullivan D, Metcalfe K, Spriggs D.

J Infect Dis. 1997 Jul;176(1):201-5.

PMID:
9207368
28.

Comparison of alternative buffers for use with a new live oral cholera vaccine, Peru-15, in outpatient volunteers.

Sack DA, Shimko J, Sack RB, Gomes JG, MacLeod K, O'Sullivan D, Spriggs D.

Infect Immun. 1997 Jun;65(6):2107-11.

Supplemental Content

Loading ...
Support Center